Gene · 406999
Papers2,102
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,102
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety. | Mol Ther Oncol | 2026 | 42733473 | PubTator, text mining | PubMed |
| Retraction: microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer. | Biosci Rep | 2026 | 42565213 | PubTator, text mining | PubMed |
| Correction: miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5. | PLoS One | 2026 | 42475271 | PubTator, text mining | PubMed |
| LINC01614 favors breast cancer progression through the regulation of miR-217/FN1 and mediation in PI3K/AKT signal pathway. | Transl Cancer Res | 2026 | 42445377 | PubTator, text mining | PubMed |
Long non-coding RNAs as molecular links and circulating biomarkers between type 2 diabetes and colorectal cancer: focus on shared signaling pathways, epigenetic regulation, and ubiquitination mechanisms. | Front Mol Biosci | 2026 | 42256316 | PubTator, text mining | PubMed |
| Urinary exosomes aggravate diabetic kidney disease by inducing podocyte ferroptosis via the miR-217/SIRT1/Nrf2 pathway. | J Cell Commun Signal | 2026 | 42039924 | PubTator, text mining | PubMed |
| MicroRNA, MicroRNA-lncRNA and MicroRNA-Circular RNA axes, and exosomal MicroRNAs: driving exercise-induced cardioprotection in heart failure. | Front Cell Dev Biol | 2026 | 41960190 | PubTator, text mining | PubMed |
| Tumor exosomes impact functional hallmarks of cancer. | Cancer Metastasis Rev | 2026 | 41912733 | PubTator, text mining | PubMed |
| Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). | Int J Oncol | 2026 | 41860028 | PubTator, text mining | PubMed |
| Emerging role of epigenetic mechanisms in glaucoma and their translational potential. | Front Genet | 2026 | 41809128 | PubTator, text mining | PubMed |
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
| Research Progress on the Biological Function, Disease-Driving Mechanism and Clinical Targeting Strategies of G3BP2. | Molecules | 2026 | 41752399 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. | Oncol Lett | 2026 | 41710085 | PubTator, text mining | PubMed |
| Pyroptosis: mechanism and therapeutic strategies with intervertebral disc degeneration. | Exp Mol Med | 2026 | 41571888 | PubTator, text mining | PubMed |
| Diagnostic value and role in promoting fracture healing of deregulated circulating miR-204 in patients with osteoporotic fractures. | J Orthop Surg Res | 2026 | 41535940 | PubTator, text mining | PubMed |
| Exploring the Functional and Prognostic Significance of miR-217 in Uterine Corpus Endometrial Carcinoma. | Curr Med Chem | 2026 | 40304329 | PubTator, text mining | PubMed |
| Nerofe+ldDox releases c-Jun from nuclear ST2 to reprogram the immune microenvironment in mtKRAS tumors. | Oncotarget | 2025 | 41459907 | PubTator, text mining | PubMed |
| Quercetin Inhibits Gastric Cancer Progression via Suppression of HOTAIR/mir-217/GPC5 Axis. | Iran J Pharm Res | 2025 | 41356665 | PubTator, text mining | PubMed |
| Circular RNA hsa_circ_0006522 correlates with unfavorable prognosis and promotes the proliferative, migrative, and invasive abilities of breast cancer cells. | Transl Cancer Res | 2025 | 41158215 | PubTator, text mining | PubMed |
| Diagnostic and prognostic potential of microRNA profiles in endometrioid endometrial cancer. | Sci Rep | 2025 | 41053314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406999/papers